This paper examines the structural components of antibodies and their role in allergic and inflammatory responses, particularly in eczema. It details the variable and constant regions of antibodies, explains the five immunoglobulin isotypes (IgA, IgD, IgE, IgG, IgM), and describes how each functions in immune defense. Special emphasis is placed on IgE's central role in triggering mast cell degranulation and the inflammatory cascade that characterizes allergic conditions. The paper connects antibody mechanisms to the pathophysiology of eczema and related allergic diseases.
Antibodies are Y-shaped proteins composed of heavy and light chains, each with distinct structural and functional regions. The variable region determines the antibody's specificity for binding to its target antigen. The tip of the Y, called the Fab region, comprises one constant region and one variable region from each heavy and light chain of the antibody.
The base of the Y, known as the Fc region, is composed of two heavy chains and is responsible for fixing complement. This region determines the biological activity of the antibody and has a constant amino acid sequence that identifies the antibody's class type. Depending on the antigen class, the Fc portions can activate complement, determine tissue distribution of antibodies, and bind to various immune cells including phagocytes, mast cells, basophils, and eosinophils.
The hinge region provides crucial mechanical flexibility, allowing each Fab arm to bind antigen while keeping the Fc region accessible to macromolecular ligands. This mobility enables the immunoglobulin to achieve bivalency—binding two antigen molecules simultaneously. The flexibility of the Fc region allows it to effectively bind to effector ligands after antibody-antigen complexes form, such as when membrane-bound Fc receptors engage with the C1 component of complement. Antibodies are initially produced as integral membrane-bound receptors on B lymphocytes before being secreted.
Antibodies are classified into five distinct isotypes based on their heavy chain constant regions: IgA, IgD, IgE, IgG, and IgM. Each isotype plays a specialized role in immune defense.
IgG is the most abundant antibody and serves critical functions in microbial defense. It neutralizes bacterial toxins and binds to microorganisms to enhance their phagocytosis, a process called opsonization. When IgG binds bacteria, the resulting complex triggers the complement system—a biochemical cascade that releases C3a and C5a fragments. These complement products attract mast cells to the site of infection through chemotaxis.
IgM is the first antibody secreted after initial contact with an antigen or allergen. Unlike other antibody types, IgM exists as a pentamer—five antibody units joined together. This pentameric structure provides ten potential antigen-binding sites, allowing IgM to effectively agglutinate (clump) bacteria and cross-link antigens.
IgD is primarily a cell surface receptor found on B lymphocytes, where it is expressed alongside IgM. Its precise function remains incompletely understood, but it appears to play a role in B cell activation and differentiation.
IgA is specialized for mucosal immunity and appears in submucosal secretions such as tears, saliva, and mucus. Its role is to defend the body against pathogens that attempt to breach exposed external surfaces. After synthesis by plasma cells, IgA is dimerized (joined as a pair) with a J-chain protein, which allows it to bind to mucosal epithelial cells. The dimer is then endocytosed across the cell cytoplasm and secreted into external body fluids following cleavage of the immunoglobulin's receptor chain.
IgE, though produced in smaller quantities than other isotypes, plays a central role in allergic and parasitic responses. When an individual is exposed to an allergen, IgE antibodies bind to high-affinity Fc receptors on mast cells and basophils. Upon subsequent allergen exposure, cross-linking of IgE on the mast cell surface triggers rapid degranulation—the release of preformed mediators such as histamine and newly synthesized mediators including leukotrienes.
This cascade of mediator release produces the characteristic symptoms of allergic reactions: itching, inflammation, vasodilation, and increased vascular permeability. In eczema, this inflammatory response is exaggerated and dysregulated, leading to the chronic itching, erythema, and skin barrier dysfunction that define the condition. Understanding IgE's mechanism is essential to comprehending why eczema and type I hypersensitivity reactions are so closely linked.
"Applying immunology to treatment"
You’re 89% through this paper. Sign up to read the remaining 1 section.
Sign Up Now — Instant Access Already a member? Log inAlways verify citation format against your institution’s current style guide requirements.